AmVac Overview

  • Founded
  • 2005
Founded
  • Status
  • Out of Business
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Liquidation

AmVac General Information

Description

Developer of vaccines designed to offer breakthrough results from basic research efficiently into the industrial development. The company's vaccines are innovative and safe that enhance human health and improve scientific understanding of immunological conditions and focuses on the fast growing vaccine market in the fields of gynecology, urology and lung diseases, enabling patients to have stimulated immune system against invading pathogens.

Contact Information

Website
www.amvac.eu
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Primary Office
  • Baarerstrasse 22
  • 6300 Zug
  • Switzerland
+41 041 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AmVac Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 01-Jan-2016 000 Completed Bankruptcy: Liquidation
3. Grant 20-Jun-2013 000.00 000 Completed Generating Revenue
2. Early Stage VC (Series A) 11-Feb-2010 $2.8M $4M Completed Startup
1. Early Stage VC $1.2M $1.2M Completed Startup
To view AmVac’s complete valuation and funding history, request access »

AmVac Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of vaccines designed to offer breakthrough results from basic research efficiently into the industrial develop
Drug Discovery
Zug, Switzerland
11 As of 2015
000
000000000000 000

00000000

it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000000000000
Westlake Village, CA
000 As of 0000
00000
000000 - 000 00000

0000 000

uptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proi
000000000000000
Stamford, CT
00 As of 0000
00000
0.000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AmVac Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MannKind Corporation Formerly VC-backed Westlake Village, CA 000 00000 000000 - 000 00000
0000 00000000 Formerly VC-backed Stamford, CT 00 00000 000000&0 00000
0000000000 0000000 Corporation Ingelheim am Rhein, Germany 00000
00000000 0000 0000 Formerly VC-backed Bannockburn, IL 0000 00000 000000&0 00000
000000000 00000000 Formerly VC-backed Zurich, Switzerland 000 00000 00000000 00000
You’re viewing 5 of 9 competitors. Get the full list »

AmVac Executive Team (4)

Name Title Board Seat Contact Info
Marian Wiegand MD Head, Research & Development
You’re viewing 1 of 4 executive team members. Get the full list »

AmVac Board Members (4)

Name Representing Role Since
Keith Luxon Self President, Supervisory Board 000 0000
Viktor Sauter Self Board Member 000 0000
You’re viewing 2 of 4 board members. Get the full list »

AmVac Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial